Back

Rethinking acute kidney injury risk: beyond contrast volume in acute myocardial infarction

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Complications secondary to acute myocardial infarction Postinfarction Period ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Catarina Lagoas Pohle

ACES Arrabida, Setubal (Portugal)

4 More presentations in this session

Presentation thumbnail
Clinical impact of secondary tricuspid regurgitation in patients following acute myocardial infarction
Doctor S. Nishino (Miyazaki, JP)
Abstract Slides Video
Presentation thumbnail
A novel 30-day mortality risk prediction scale in patients with acute inferior myocardial infarction with electrical extension to the right ventricle undergoing a reperfusion strategy.
Doctor G. Navarrete Alvarado (Mexico City, MX)
Abstract Slides Video
Presentation thumbnail
Predictors of acute kidney injury rates in patients admitted with ST-elevation myocardial infarctions complicated by cardiogenic shock
Doctor J. Schmucker (Bremen, DE)
Abstract Slides Video
Presentation thumbnail
Predictors and prognostic impact of arrhythmic complications in ST-segment elevation myocardial infarction
Doctor A. Maida (Bologna, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Complications secondary to acute myocardial infarction

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Predictors of acute kidney injury rates in patients admitted with ST-elevation myocardial infarctions complicated by cardiogenic shock
thumbnail
Congress Presentation
The impact of acute kidney injury on survival in males and females undergoing high-risk percutaneous coronary interventions with Impella support
thumbnail
Congress Presentation
SGLT2 inhibitors on the prevention of contrast-induced acute kidney injury in patients with type 2 diabetes after coronary revascularization: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources